Continuous Glucose Monitoring and Long-Term Glycemic and Kidney Outcomes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Continuous Glucose Monitoring in Relation to Long-Term Glycemic Control and Kidney Outcomes

  • By

  • Andrew J. Karter

  • Melissa M. Parker

  • Holly Finertie

  • Joshua R. Nugent

  • Lisa K. Gilliam

  • Ajit Mahapatra

  • October 7, 2026

Share

  • 1

    The study emulated a target trial to assess sustained real-time continuous glucose monitoring (rtCGM) and long-term glycemic and kidney outcomes in adults with type 2 diabetes.

  • 2

    Eligible adults had poor glycemic control, defined as hemoglobin A1c greater than 8%, or a recent history of hypoglycemia.

  • 3

    The analysis compared rtCGM initiators with temporally matched controls who had not initiated continuous glucose monitoring.

  • 4

    Participants were followed for up to 36 months, with follow-up ending after exposure changes, loss of coverage, death, or study termination.

  • 5

    Outcomes included hemoglobin A1c, urinary albumin-creatinine ratio, and estimated glomerular filtration rate measured through outpatient laboratory testing.

Original Source(s)

Continuous Glucose Monitoring and Long-Term Glycemic and Kidney Outcomes

  • by Andrew J. Karter, Melissa M. Parker, Holly Finertie, Joshua R. Nugent, Lisa K. Gilliam, Ajit Mahapatra

  • October 7, 2026

Related Content

Early Catch-Down Growth in the Offspring of Mothers With Gestational Diabetes

Medical Oddities: Your physiology may know when you're alone

The body gets weird this week with company, cavities, phantom smells, and black tea.

HHS Issues Final Demand to Medical Organizations to Answer for Sex-Rejecting Procedures for Minors